Merlin: the wizard requires protein stability to function as a tumor suppressor.

作者: K. Adam Morrow , Lalita A. Shevde

DOI: 10.1016/J.BBCAN.2012.06.005

关键词: MoesinProtein familyCell biologyEpigeneticsEzrinMerlin (protein)RadixinNeurofibromatosis type 2GeneticsBiologyTumor microenvironment

摘要: Neurofibromatosis type 2 (NF2), characterized by tumors of the nervous system, is a result functional loss NF2 gene. The gene encodes Merlin (moesin–ezrin–radixin-like protein), an ERM (Ezrin, Radixin, Moesin) protein family member. functions as tumor suppressor through impacting mechanisms related to proliferation, apoptosis, survival, motility, adhesion, and invasion. Several studies have summarized intrinsic mutations in Merlin. Given fact that cells are not isolation, but rather intricate, mutually sustaining synergy with their surrounding stroma, dialog between stroma can potentially impact molecular homeostasis promote evolution malignant phenotype. This review summarizes epigenetic modifications, transcript stability, post-translational modifications We reviewed role extrinsic factors originating from milieu influence availability inside cell. Information regarding regulation could lead novel therapeutics stabilizing reduced expression without displaying any genetic alterations.

参考文章(108)
Minja Laulajainen, Taru Muranen, Tuula A Nyman, Olli Carpén, Mikaela Grönholm, Multistep Phosphorylation by Oncogenic Kinases Enhances the Degradation of the NF2 Tumor Suppressor Merlin Neoplasia. ,vol. 13, pp. 643- 652 ,(2011) , 10.1593/NEO.11356
H. Maruta, Anjali Tikoo, M. Varga, Vijaya Ramesh, J. Gusella, An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). Journal of Biological Chemistry. ,vol. 269, pp. 23387- 23390 ,(1994) , 10.1016/S0021-9258(17)31525-9
D. S. Malley, V. P. Collins, K. Ichimura, P. J. Kullar, D. M. Pearson, CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas. Neuropathology and Applied Neurobiology. ,vol. 36, pp. 505- 514 ,(2010) , 10.1111/J.1365-2990.2010.01090.X
Caisa M Hansson, Patrick G Buckley, Giedre Grigelioniene, Arkadiusz Piotrowski, Anders R Hellström, Kiran Mantripragada, Caroline Jarbo, Tiit Mathiesen, Jan P Dumanski, Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus BMC Genomics. ,vol. 8, pp. 16- 16 ,(2007) , 10.1186/1471-2164-8-16
Carol Aghajanian, Sandra Pezzulli, Martee L. Hensley, Christine S. Pien, Don S. Dizon, Paul Sabbatini, Vincent Miller, Christina Canales, Adil Daud, Peter J. Elliott, Steven Soignet, Julian Adams, David R. Spriggs, A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies. Clinical Cancer Research. ,vol. 8, pp. 2505- 2511 ,(2002)
Fumiaki Okahara, Hideki Ikawa, Yasunori Kanaho, Tomohiko Maehama, Regulation of PTEN Phosphorylation and Stability by a Tumor Suppressor Candidate Protein Journal of Biological Chemistry. ,vol. 279, pp. 45300- 45303 ,(2004) , 10.1074/JBC.C400377200
Kyoko Kitagawa, Yojiro Kotake, Masatoshi Kitagawa, Ubiquitin‐mediated control of oncogene and tumor suppressor gene products Cancer Science. ,vol. 100, pp. 1374- 1381 ,(2009) , 10.1111/J.1349-7006.2009.01196.X
Xiaoling Tang, Sung-Wuk Jang, Xuerong Wang, Zhixue Liu, Scott M Bahr, Shi-Yong Sun, Daniel Brat, David H Gutmann, Keqiang Ye, None, Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation Nature Cell Biology. ,vol. 9, pp. 1199- 1207 ,(2007) , 10.1038/NCB1641
D.G. Evans, E. Howard, C. Giblin, T. Clancy, H. Spencer, S.M. Huson, F. Lalloo, Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. American Journal of Medical Genetics Part A. ,vol. 152, pp. 327- 332 ,(2010) , 10.1002/AJMG.A.33139